Bruker Acquires Spectral Instruments Imaging, the Performance Leader in Preclinical In-Vivo Optical Imaging Systems Post author: Post published:February 7, 2024 Post category:uncategorized Acquisition Complements Bruker’s Preclinical Imaging Portfolio with In-Vivo Optical Imaging You Might Also Like Can People with Type 1 Diabetes Also Get Type 2? April 9, 2024 Study identifies cost-effective strategies for using AI in health systems November 18, 2024 Disrupted body clocks raise risk of early death, study finds April 29, 2025